Table 1 Experimental design outlining the number of frogs from each population and treatment group (Bd exposed or unexposed control) sampled at each time point post exposure.
Populations | Exposure – Day 0 Total # exposed (total # control)a | Day 4 # exposed sampled (# control sampled)b | Day 8 # exposed sampled (# control sampled)b | Day 14 # exposed sampled (# control sampled)b | Clinically diseased (Day 28+) # exposed sampled |
|---|---|---|---|---|---|
Grey Mare | 16 (3) | 4 (1) | 4 (1) | 4 (1) | 4 |
Eucumbene | 14 (6) | 4 (2) | 4 (2) | 4 (2) | 2 |
Kiandra | 14 (6) | 4 (2) | 4 (2) | 4 (2) | 2 |
Ogilvies | 2 | — | — | — | 2 |